Morning Break: Roundup Settlement? Not-So-Sterile Gowns; Faulty E-Cig Devices

— Health news and commentary from around the Web gathered by the MedPage Today staff

MedpageToday

Note that some links may require subscriptions. Also, Monday is a MedPage Today holiday and Morning Break will not appear. Look for it again on Tuesday, January 21.

Germany-based Bayer might be close to settling more than 75,000 cancer claims by users of the popular weedkiller Roundup. (Reuters)

China confirmed a second death from the pneumonia-like outbreak tied to the Wuhan fish market. (CNN)

The FDA and Cardinal Health cautioned the latter's customers not to use certain Level 3 surgical gowns and PreSource procedural packs because the garments might not be sterile.

Public health officials in Travis County, Texas, which includes Austin, reported the county's first confirmed case of rubella in more than 20 years. (Austin American-Statesman)

Major League Baseball and the players' union announced a $3 million grant program to support advocacy groups and initiatives related to mental health, relationship skills, and domestic violence. (AP News)

Since the Democratic Republic of the Congo's current Ebola outbreak was recognized in May 2018, the total number of confirmed and probable cases now stands at 3,406, including 2,236 deaths. (WHO)

Ob/gyns have a simple message about using madura sticks for vaginal rejuvenation: Don't do it. (Newsweek)

The latest CDC case count for acute lung injury related to vaping: 2,668, with 60 deaths.

Over a 3-year period, users of Juul e-cigarettes filed 1.3 million complaints about the devices, including 156,000 reports of potentially harmful leaky pods. (Tech Times, Bloomberg)

Another take on the "use it or lose it" adage: Reproductive-age women who have sex less often than once a month may have an increased risk of early menopause. (Fox News)

In the first full year after FDA approval, the CBD drug Epidiolex brought in almost $300 million for GW Pharma, including $104 million in the last quarter of 2019. (CNBC)

FDA approved a new indication for semaglutide (Ozempic): to reduce the risk of major cardiac events in type 2 diabetes patients with heart disease, Novo Nordisk announced.

As the new year kicks off, high-deductible health insurance policies kick in: Some tips for minimizing the financial pain. (NBC News)

Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com